Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
主要な著者: | Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Nature Portfolio
2024-08-01
|
シリーズ: | Communications Biology |
オンライン・アクセス: | https://doi.org/10.1038/s42003-024-06659-8 |
類似資料
-
PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
著者:: S. De Taeye, 等
出版事項: (2022-12-01) -
A functional spleen contributes to afucosylated IgG in humans
著者:: Iwona Wojcik, 等
出版事項: (2021-12-01) -
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
著者:: Mary Lopez-Perez, 等
出版事項: (2025-01-01) -
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
著者:: Angela I. Schriek, 等
出版事項: (2022-11-01) -
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
著者:: Angela I. Schriek, 等
出版事項: (2022-05-01)